The role of circulating tumor DNA in precision adjuvant therapy for colorectal cancer: a scoping review
{{output}}
Background: Recurrence of colorectal cancer (CRC) after curative-intent treatment is largely driven by minimal residual disease (MRD). Circulating tumor DNA (ctDNA) offers a noninvasive approach to detect MRD and tailor adjuvant ... ...
